FindTrial
Sign In

Clinical study of early diagnosis and prognosis evaluation of lncRNA in acute coronary syndrome

Clinical study of early diagnosis and prognosis evaluation of lncRNA in acute coronary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017617
Enrollment
Unknown
Registered
2018-08-07
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

Gold Standard:Troponin I and intravenous ultrasound (IVUS)
Index test:LncRNA

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: According to the 2015 ESC guidelines for acute coronary syndrome, 400 patients with acute coronary syndrome (including unstable angina pectoris, acute non-ST-segment elevation myocardial infarction, acute ST-segment elevation myocardial infarction) were included in the study.

Exclusion criteria

Exclusion criteria: (1) had undergone PCI or CABG surgery; (2) heart disease other than coronary heart disease such as valvular disease, cardiomyopathy, etc.; (3) various acute and chronic infections with clear infections, severe liver and kidney diseases, and blood system diseases , rheumatism, immune diseases, malignant tumors; (4) under 18 years of age; (5) pregnant and lactating women; (6) patients with mental disorders; (7) refuse to sign informed consent and refuse to provide information.

Design outcomes

Primary

MeasureTime frame
lncRNA;SPE, SEN, ACC, ROC and AUC;—

Countries

China

Contacts

Public ContactMin Zhang

Shanghai Chest Hospital

zhangminxk@126.com+86 18017320207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026